JUPITER, FL - Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company currently valued at $34.1 million, has announced a partnership with Catalent (NYSE:CTLT) Pharma ...
Discover how boxing is transforming lives across America, offering a unique therapeutic outlet for those battling PTSD, anger ...